Find your path to Theresa
79 people in our graph share verified history with Theresa — schools, employers, funds. One of them is your warm intro.
Nick KaiserunlockedTheresa: together at UC Santa Barbara (1995–1996)
×10Theresa: together at UC Santa Barbara
Theresa: together at Jennerex Biotherapeutics
Executive at 4D Molecular Therapeutics
Intro paths
→
In turn, Theresa can intro founders to 4D Molecular Therapeutics's investors below.
4D Molecular Therapeutics's investors · 10
Amzak HealthNew York · since 2020Berkeley CatalystBerkeleyBiotechnology Value FundSan Francisco · since 2020BOLD LongevityBostonCasdin CapitalNew York · since 2020Chiesi VenturesBoston · $5M checksPappas CapitalDurhamPfizer Venture Investments$5M – $20M checksPfizer Venturessince 2020Viking Global InvestorsStamford · since 2020
Co-founders at 4D Molecular Therapeutics
DK
David KirnExecutive Officer, Director
DS
David SchafferDirector
Experience
- 4D Molecular TherapeuticsChief Of Staffcurrent2021 — presentEmeryville, California, United States
- 4D Molecular TherapeuticsChief Strategy Officer2020 — 2021
- 4D Molecular TherapeuticsChief Operating Officer2018 — 2020
- IGNITE ImmunotherapyCo-founder and Board member2016 — 2019SF Bay Area
- CelgeneDirector, Clinical Research & Development - Strategy and Alliances (consultant)2013 — 2014San Francisco Bay Area
- Jennerex BiotherapeuticsDirector of Clinical Operations2012 — 2013
- Jennerex BiotherapeuticsSenior Clinical Project Manager2007 — 2012
- Abbott VascularSenior Clinical Research Associate2006 — 2007
Skills & more
Drug DevelopmentClinical Research
From Theresa's professional profile.
Frequently asked questions
- Who is Theresa Janke?
- Executive Officer at 4D Molecular Therapeutics
- Where does Theresa Janke work?
- Theresa Janke is Executive at 4D Molecular Therapeutics.
- Where did Theresa Janke go to school?
- Theresa Janke studied at UC Santa Barbara (Bachelor of Science (BS), Biopsychology).
Same school
Also attended UC Santa Barbara490
Logan GreenCo-founder of LyftJen WangDeal Operations Manager at Felicis VenturesArturo LitvinHead of Global Portfolio Development at Intel CapitalKevin ThauInvestor at Spark CapitalErica DelamareInvestor at DaphniDanielle RomanowskiExecutive Assistant at Sapphire Ventures
+ 484 more
Shared employers
Also worked at 4D Molecular Therapeutics6
Neil LittmanManaging Partner at BiovergeAvery KalafatasInvestor at Insight PartnersMelissa KottermanVenture Partner at Berkeley FrontierDavid SchafferProfessor of Bioengineering; Co-founder, 4D Molecular and Axent Biosciences (Faculty Advisor) at UC Berkeley SkydeckDavid KirnExecutive Officer, Director at 4D Molecular TherapeuticsCarlos Quezada-RuizChief Medical Officer at Alkeuspharma
Also worked at Celgene41
Courtney WallaceInvestor at Third Rock VenturesJoyce BremerInvestor at True VenturesPatrick LoerchBio Advisor at Amplify PartnersGeorge GolumbeskiPartner at Droia VenturesMichael KramarzManaging Partner at Commodore CapitalLisa WisniewskiManaging Director at Global BioAccess Fund
+ 35 more
Also worked at Jennerex Biotherapeutics5
Also worked at Abbott Vascular195
Daan BoekhoudtInvestment Analyst at Cottonwood Technology FundClaire YoonAssociate at Scale Venture PartnersMary PattonScientific Advisory Board at InnoCom Bio EquitiesJim CaggianoChief Executive Officer, Evolve Biologics at Two Bear CapitalLaura QuockCBO-in-Residence at Versant VenturesCharles BeyrouthyFounder & Managing Partner at Forma Prime
+ 189 more